Multidisciplinary Clinical Case Study

Uremic Pericarditis: Distinguishing Features in a Now-Uncommon Clinical Syndrome

We present the case of a 47-year-old man with a history of diabetes mellitus and diabetic nephropathy who was admitted to our hospital with acute uremic myopericarditis. Echocardiography demonstrated a fibrinous pericardial effusion. The patient was initiated on hemodialysis for hyperkalemia, metabolic acidosis, and uremia. He subsequently developed shock from…

Posted in: cardiac tamponade 7 end-stage renal disease 5 pericardial effusion 4

Original Article

Transfusion Requirements in ESRD Patients Admitted with GI Hemorrhage Undergoing Inpatient Endoscopy

Objectives: To date there are no studies evaluating the utilization of blood products in patients with end-stage renal disease (ESRD) with gastrointestinal (GI) hemorrhage. This study estimated transfusion needs and determined predictors available at the time of admission for patients with ESRD admitted to a university hospital with GI bleeding…

Posted in: bleeding 6 end-stage renal disease 5 gastrointestinal 5 hemorrhage 7 transfusion 5

Original Article

Blood B-Type Natriuretic Peptide and Dialysis: Present Assessment and Future Analyses

Brain natriuretic peptide (BNP) is elevated in hemodialysis (HD) patients and predicts increased mortality. Intra- and interdialytic changes in BNP have not been fully described. End-stage renal disease (ESRD) patients were prospectively recruited at three dialysis centers. At five visits, over a 6-week period, pre- and postdialysis BNP levels were…

Posted in: end-stage renal disease 5 hemodialysis 9

Expired CME Article

Clinical Considerations and Practical Recommendations for the Primary Care Practitioner in the Management of Anemia of Chronic Kidney Disease

Anemia is prevalent in patients with chronic kidney disease (CKD) and is a risk factor for poor disease outcome. Anemia acts as a risk multiplier, significantly increasing the risk of death in anemic versus nonanemic CKD patients with similar comorbidities. Erythropoiesis-stimulating agents (ESA) are a mainstay for the treatment of…

Posted in: Cardiovascular Disease 27 chronic kidney disease 13 end-stage renal disease 5 erythropoietin 2 hemoglobin 3

Expired CME Article

Hemodialysis for the Non-nephrologist

Hemodialysis is now routinely provided to more than 300,000 patients in the United States. An epidemic of end-stage renal disease will nearly double this number by 2010. Patients undergoing chronic hemodialysis have high morbidity and mortality rates. Given these facts, most medical providers will be involved in the care of…

Posted in: complications 13 end-stage renal disease 5 hemodialysis 9
SMA Menu